Elevance Health, one of the largest US health insurers, raised its full-year profit forecast on the back of a third-quarter earnings beat, as medical costs came in cooler than expected even as membership declined. The company now expects adjusted earnings of at least $29 per share for the full year, up from its previous guidance of at least $27, and above the $27.23 consensus tracked by LSEG.
The upbeat outlook comes after a rough stretch for US health insurers, who have grappled with choppy membership numbers and rising costs in government-backed plans, driven by higher demand for behavioral health care and expensive specialty drugs. Elevance's results suggest that pressure may be easing, at least for now.
Medical costs cool, but membership slips
In the third quarter, Elevance's medical loss ratio (MLR) – the share of premiums spent on members' medical care – came in at 90.6%, below the 91.17% analysts had expected. A lower MLR means the company spent less of its premium revenue on medical claims, which is generally a positive sign for profitability.
Management pointed to better year-on-year performance in its Medicare Advantage and Affordable Care Act (ACA) plans, two key growth areas that have been under pressure across the industry. Medicare Advantage, the private version of the federal health program for seniors, has been a particular focus for insurers as they navigate regulatory changes and cost pressures.
However, membership still fell to about 44.9 million by September 30th, down 487,000 from a year earlier. That decline reflects the broader industry trend of choppy enrollment, especially in government programs where members may switch plans or drop coverage.
Despite the membership drop, Elevance's insurance revenue rose by $1.1 billion year-on-year, helped by higher premium yields and service fees. That combination – lower medical costs and higher revenue per member – gave management enough confidence to lift the full-year outlook.
What the earnings beat really means
At first glance, Elevance's quarter looks like a huge beat: adjusted earnings were $6.99 per share versus the $4.68 analysts expected. But about $1.85 of that came from a non-operating benefit, which analysts typically treat as less repeatable when they update forecasts. So rather than chasing the headline number, investors will likely focus on whether the core insurance business is improving.
The lower MLR and management's comments on Medicare Advantage and ACA performance are more telling. If those drivers hold up, they do more to support a higher full-year outlook than a one-off accounting lift. Mizuho, an investment bank, said the report suggests Elevance is “on the path to margin recovery” in key segments.
For everyday investors, the key takeaway is that Elevance's results are a positive signal for the health insurance sector, which has been under pressure. But it's important to look beyond the headline earnings number and consider the quality of the beat. Non-operating gains can inflate results, so the focus should be on the underlying business trends.
What it means for investors
Elevance's raised outlook is a sign that the company sees better days ahead, but it's not a green light to buy the stock. The membership decline is a concern, and the non-operating boost means the beat is not as strong as it appears. Investors should watch whether the lower MLR is sustainable and whether membership stabilizes in the coming quarters.
In the broader market, health insurers have been a mixed bag. Some have struggled with rising costs, while others have managed to navigate the challenges. Elevance's results could provide a lift to the sector, but it's too early to say if the trend is broad-based. As always, it's wise to diversify and not put all your eggs in one basket.
For those interested in the broader earnings season, other companies have also been reporting mixed results. For instance, NextEra's profit beat was driven by its renewables unit, while Super Micro jumped on AI sales but Netflix dropped on a weak outlook. And AT&T raised its forecast thanks to bundled plans. Each story highlights the importance of looking at the details behind the numbers.
Elevance's next earnings report will be closely watched to see if the margin recovery continues and whether membership trends improve. Until then, investors should keep an eye on the company's core metrics rather than the headline profit figure.
